The increased levels of FoxP3+/−Helios+GARP+LAP+ Tregs in LICRC patients could be attributed to the advanced metastatic stage of these patients, and the associated tumour-mediated immunosuppression that could be expected. The gene discussed is TGFB1; the disease is neoplasm.